Search

Your search keyword '"Valentino, Leonard A."' showing total 498 results

Search Constraints

Start Over You searched for: Author "Valentino, Leonard A." Remove constraint Author: "Valentino, Leonard A."
498 results on '"Valentino, Leonard A."'

Search Results

68. Women and girls’ participation in haemophilia clinical trials.

69. A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

71. Control of disseminated intravascular coagulation in Klippel-Trenaunay-Weber syndrome using enoxaparin and recombinant activated factor VIIa: a case report

74. Pushing the frontiers of medicine: innovations in haemophilia care.

77. Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement.

78. The role of ultralarge multimers in recombinant human von Willebrand factor – a review of physico-and biochemical studies and findings in in vivo models and in humans with von Willebrand disease

80. Modelling FVIII Levels for Prediction of Zero Spontaneous-Joint Bleeding in a Cohort of Severe Hemophilia a Subjects with Target Joints Initiated on Tertiary Prophylaxis

84. Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes.

85. Emicizumab: Review of the literature and critical appraisal.

86. Walking the Walk: Inclusion of Lived Experience Experts in the Design of the National Hemophilia Foundation's National Research Blueprint for Those Living with Inherited Bleeding Disorders

87. Hemophilia in the virtual clinic: Using telemedicine to manage chronic disease

90. Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy : results from the von Willebrand Disease Prophylaxis Network

91. Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network

92. Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy

95. Rituximab for treatment of inhibitors in haemophilia A

98. Long-Term Orthopedic Effects Of Delaying Prophylaxis In Severe Hemophilia A Until Age 6 Years: Results Of The Joint Outcome Study Continuation (JOSc)

100. Pharmacokinetics, Safety, and Efficacy Of Long-Lasting Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Adolescent Subjects With Hemophilia B: A Subgroup Analysis Of The B-LONG Study

Catalog

Books, media, physical & digital resources